Alliance Pharma plc
APH
Delayed London Stock Exchange - 07/19 03:33:24 pm
95.52GBp
-1.53%
Prev.97.0000
Open96.4000
High98.0000
Low95.2000
Volume363 641
Financials
Sales 2018 124 M
EBIT 2018 31,5 M
R. net 2018 22,4 M
Debt 2018 68,0 M
Rend. 2018 1,52%
P/E ratio 2018 21,09
P/E ratio 2019 19,21
EV / Sales 2018 4,60x
EV / Sales 2019 3,97x
Capitalization 503 M
Company
Alliance Pharma Plc operates as a pharmaceutical company.It manufactures, develops, markets and distributes pharmaceutical products.The company principal activities are the acquisition and licensing of mature pharmaceutical products and the marketing of those products.Its portfolio includes brand...
Sector :
Generic Pharmaceuticals
Calendar :
2018-09-12 Earnings Release
Trading Rating :
Investor Rating :
Latest news
07/06ALLIANCE PHARMA : Marketing Authorisation for Diclectin in the UK
PU
07/06ALLIANCE PHARMA : Marketing Authorisation for Diclectin
PU
06/21ALLIANCE PHARMA : Completion of Acquisition and TVR
PU
06/19ALLIANCE PHARMA : Result of Placing
PU
06/19ALLIANCE PHARMA : Nizoral Acquisition in APAC and Proposed Placing
PU
06/14ALLIANCE PHARMA PLC : Ex-dividend day for final dividend
FA
06/07ALLIANCE PHARMA : Positive Opinion on Diclectin
PU
05/16ALLIANCE PHARMA : Notification of Major Holdings
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance102102101
Spread/Res.-6,4%-6,4%-5,4%
Spread/Supp.2,7%13%40%
Support93,084,268,0